NCT03672292Phase 2Terminated

Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis

Study sponsor: Scynexis, Inc. · SCYX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-03-27Actual
Enrollment · participants22Actual
Source updated2024-08-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview